Alpha Omega is expanding operation in China after receiving CFDA for Neuro Omega
Alpha Omega Engineering received CFDA certificate for Neuro Omega - innovative Microelectrode Recording (MER) system used for advanced localization of surgical targets in Deep Brain Stimulation (DBS) for treatment of neurological and psychiatric disorders.
About Neuro Omega System
FDA cleared, Health Canada licensed, CE approved, and now CFDA registered Neuro Omega enables neurosurgeons to locate the optimal target for the implantation of Deep Brain Stimulation (DBS) Electrodes. The system can be used for advanced research needs as well.
“Alpha Omega Research and Development continues to set the pace for new and innovative hardware and software in the field of DBS navigation technologies which enhances the expansion of the procedure and widens its accessibility to all patients to improve their quality of life." - Imad Younis, President of Alpha Omega.
About Alpha Omega
Founded in 1993, Alpha Omega is a world-leading medical device company, specializing in neurosurgery and neuroscience. The company offers solutions for enhancing and simplifying Deep Brain Stimulation (DBS), by implementing sophisticated software and hardware for brain mapping and navigation.
Alpha Omega in China
Obtaining the CFDA Certificate for NeuroOmega is another significant milestone for Alpha Omega, that has already entered the Chinese market with NeuroNav (Compact MER solution) and established a genuine connection with Neurosurgeons and Neuroscientist communities. This is a colossal step towards Alpha Omega's growth in the China market.
- Latest News